We are redefining infectious disease care with the first instrument-free, rapid, phenotypic, point-of-care test to remove guesswork from antibiotic prescribing and personalize drug selection. Starting with UTIs, Latde is building a platform with broad clinical and non-clinical applications.
| Website | https://latde-dx.com/ |
| Employees | 7 (3 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Antibiotic Stewardship, Rapid Diagnostic Tests, Infection Diagnostics, Infection Detection, Point Of Care Diagnostics, Antibiotic Resistance, Microbial Diagnostics, Diagnostic Tools, Affordable Diagnostics, Accessible Diagnostics, Clinical Diagnostics, Infectious Disease Diagnostics, Healthcare Diagnostics, Medical Diagnostics, Diagnostic Devices, In Vitro Diagnostics, Rapid Diagnostics |
| Competitors | Siemens, Roche, Thermo Fisher Scientific, Abbott, BD, bioMérieux, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, OriGene Technologies, Inc +44 more (view full list) |
Looking for a particular Latde Diagnostics employee's phone or email?
Emily Melzer is the CEO of Latde Diagnostics.
3 people are employed at Latde Diagnostics.
Latde Diagnostics is based in Amherst, Massachusetts.